Previous 10 | Next 10 |
NEW YORK, NY / ACCESSWIRE / April 7, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate whether the following proposed mergers are fair to shareholders. Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the ...
BNT111 FixVac Melanoma registrational trial start planned for 2H 2020 BNT121 (iNeST) adjuvant Phase 2 study in NSCLC to start in 2H 2020 COVID-19 vaccine program BNT162 set to enter the clinic in April 2020 Ended 2019 with cash equivalents of $583 million ( €520 millio...
NEW YORK, March 24, 2020 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate whether the following proposed mergers are fair to shareholders. Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning th...
Biomerica (NASDAQ: BMRA ) +133% on advancement of rapid coronavirus test. More news on: Biomerica, Inc., IMV Inc., Vaxart, Inc., Stocks on the move, , Read more ...
BioNTech SE (NASDAQ: BNTX ) +55% on teaming up with Pfizer teams to develop COVID-19 vaccine. More news on: BioNTech SE, Co-Diagnostics, Inc., Neon Therapeutics, Inc., Stocks on the move, , Read more ...
OpGen (NASDAQ: OPGN ) +74% on being beneficiaries related to COVID-19. More news on: OpGen, Inc., BioNTech SE, Neon Therapeutics, Inc., Stocks on the move, , Read more ...
NEW YORK, March 12, 2020 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate whether the following proposed mergers are fair to shareholders. Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning th...
NEW YORK, March 11, 2020 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (NASDAQ:NTGN) Lifshitz & Miller announces investigation into possible breach of fiduciary duties in connection with the sale of NTGN to BioNTech SE. If you are a NTGN investor, and would like additional info...
Merger activity increased last week with four new deals announced and two deals closing. Out of the four deals announced, three were cash deals and one was an all-stock deal. The acquisition of Forty Seven ([[FTSV]]) by Gilead Sciences ([[GILD]]) was the first deal announced last week. FTSV ...
NEW YORK, NY / ACCESSWIRE / March 9, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate whether the following proposed mergers are fair to shareholders. Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the ...
News, Short Squeeze, Breakout and More Instantly...
Neon Therapeutics Inc. Company Name:
NTGN Stock Symbol:
NASDAQ Market:
Neon Therapeutics Inc. Website:
CAMBRIDGE, Mass., April 30, 2020 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (Nasdaq: NTGN) today announced the acceptance of its Clinical Trial Authorization (CTA) from the Dutch Health Authority (DHA) for its personal neoantigen-targeted T cell therapy candidate, NEO-PTC-01. Neon...
BNT111 FixVac Melanoma registrational trial start planned for 2H 2020 BNT121 (iNeST) adjuvant Phase 2 study in NSCLC to start in 2H 2020 COVID-19 vaccine program BNT162 set to enter the clinic in April 2020 Ended 2019 with cash equivalents of $583 million ( €520 millio...
NEW YORK, NY / ACCESSWIRE / February 13, 2020 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: Forescout Technologies, Inc. (NASDAQ: FSCT )...